Industry News
Medical Device Industry News
7 Wellness Tips for Chiropractic Patients to Speed Healing and Maintain Health
To maximize the benefits of chiropractic care and ensure a speedy recovery, patients should incorporate several wellness practices into their daily routines. Here are seven essential wellness tips for chiropractic patients aiming to speed healing
BD Drops $4.2B for Edwards’ Critical Care Unit
The transcatheter aortic valve replacement pioneer announced it would spin out the Critical Care unit in December 2023.
Cardinal Health Redesigns Packaging to Slash Waste
According to its recently released ESG Report, the organization expects the change to eliminate more than 169,000 pounds of packaging waste in fiscal 2024.
Plastic Gears Are Enabling Today’s Advanced Applications
Here’s what to consider, whether you’re converting from metal to plastic gears or designing gears for a novel device.
What You Need to Know About the Artificial Intelligence Act
European Union states greenlit a measure to regulate artificial intelligence. The sweeping law is the first of its kind and will have a definitive impact on any companies that employ the use of AI. Anne-Gabrielle
OptumHealth Nimbus II Pump System Identified as Class I Recall
The company has informed customers that the system will no longer be available or supported after June 20.
Could Simulation Advance Your Testing Programs?
Computational modeling and simulation testing could help expand testing options during medical device development.
Akili to Go Private Through Merger with Virtual Therapeutics
Akili had all the ingredients for success. It was in the prescription therapeutics space and went through a high-profile special purpose acquisition corporation merger. Now, the company, once valued at about $1 billion, is being
Reduce Risk & Increase Impact: Building a Smarter MVP in Medtech
A good minimum viable product can help convince stakeholders, validate concepts, and provide crucial momentum for startups.
Medtech Recall Round-Up: May 2024
This month, companies including Philips Respironics, Abbott, and Masimo were caught in the crosshairs of FDA ire.
ExpressionEdits Raises $13M in Seed Funding to Advance Protein Expression Using AI-Driven Intronization Technology
The funding will accelerate candidate selection for preclinical studies and develop a pipeline of protein-based therapeutics. The primary focus for the pipeline will be recombinant proteins that have historically faced production and manufacturing challenges based
Mark Eisner MD, M.P.H. Appointed Chief Medical Officer at Vir Biotechnology
Mark Eisner MD comes from Sonoma Biotherapeutics, Inc., where he most recently held the position of CMO. In this role, he led all development functions which included biometrics, regulatory, clinical science, clinical operations, drug safety,
Tris Pharma Receives U.S. FDA Approval for Once-Daily ONYDA XR (clonidine hydrochloride) Extended-Release Oral Suspension, the First-and-Only Liquid Non-Stimulant ADHD Medication
ONYDA XR is indicated for the treatment of ADHD as monotherapy or as adjunctive therapy to approved CNS stimulant medications in pediatric patients six years and older. The first non-stimulant ADHD medication, with nighttime dosing,
VUZE Medical Announces U.S. FDA 510(K) Clearance for Second-Generation Software-Based 3D Guidance System for Spine Surgery
VUZE 2.0 provides much-extended interoperability and functionality; like VUZE 1.0, requires only a 2D C-arm and PC in the OR -- no cameras, markers, references or tool add-ons.
Stryker Reports: 1st European Surgeries Completed Using Stryker’s Gamma4 Hip Fracture Nailing System
The Gamma4 Hip Fracture Nailing System is designed to treat hip and femur fractures. Its nail design is informed by Stryker's SOMA database, which includes over 37,000 3D bone models generated from CT scans. The
Northwell Cardiothoracic Programs Have Nation’s Highest Success Rates
5 Northwell Cardiothoracic Programs (Northwell) include: Long Island Jewish Hospital, Lenox Hill Hospital, South Shore University Hospital, Staten Island University Hospital and the Sandra Atlas Bass Heart Hospital at North Shore University Hospital – received
Tumor Ablation Market Worth $1.4 Billion
The tumor Ablation Market in terms of revenue was estimated to be worth $0.8 billion in 2024 and is poised to reach $1.4 billion by 2029, growing at a CAGR of 10.0% from 2024 to
Private Equity Firm Set to Acquire Surmodics for $627M
The deal is expected to close in the second half of this year.
Global Smart Pills Market to Surge at a CAGR of ~11% by 2030
DelveInsight's Smart Pills Market Insights report provides the current and forecast market analysis, individual leading smart pills companies' market shares, challenges, smart pills market drivers, barriers, trends, and key market smart pills companies in the
Franck Mevellec Appointed Senior Director, Business Development at Asymchem
Franck Mevellec boasts a proven track record of success, having held key positions at industry leaders like Bayer Healthcare (R&D), Teva Pharmaceuticals (portfolio director), Minakem (BD director), and most recently, Seqens (global head of sales).